Patent · US Revoked

Treatment for pancreatic cancer

US9555042B2 · kind B2 · utility

0Cited by
13References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2014
Grant dateJan 31, 2017
Priority date
Expiry dateOct 3, 2034

Classification

  • Technology area (CPC —)General

Abstract

The invention is related to a method of treating a subject with pancreatic cancer with administration of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.